InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.14
(
-0.40%
)
Bitcoin
60,946.51
(
0.22%
)
Post# of 21373
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dabullishbear

Send PM Follow Ignore
Followers 23
Posts 1725
Boards Moderated 0
Alias Born 09/03/2015

dabullishbear

Re: Rat Fink post# 18192

Friday, 08/10/2018 12:14:40 PM

Friday, August 10, 2018 12:14:40 PM

Post# of 21373
I keep finding studies that are recent in regards to Prolanta (G129R). This article was published August 3rd 2018. Does this mean that Prolanta is being actively studied and tested?

http://beatingcancercenter.com/2012-11-24-22-19-50/related-researches/2000-2009/2379-additive-effects-of-a-prolactin-receptor-antagonist-g129r-and-herceptin-on-inhibition-of-her2-overexpressing-breast-cancer-cells.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up